PureTech Health plc (NASDAQ:PRTC - Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $20.41, but opened at $21.69. PureTech Health shares last traded at $21.68, with a volume of 844 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on PRTC shares. Leerink Partners started coverage on PureTech Health in a research report on Monday, September 9th. They set an "outperform" rating and a $45.00 price objective on the stock. Leerink Partnrs upgraded PureTech Health to a "strong-buy" rating in a research report on Monday, September 9th.
View Our Latest Research Report on PureTech Health
PureTech Health Trading Up 0.8 %
The business has a 50-day moving average of $20.83 and a two-hundred day moving average of $24.22.
Institutional Investors Weigh In On PureTech Health
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. purchased a new stake in PureTech Health plc (NASDAQ:PRTC - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 6,900 shares of the company's stock, valued at approximately $197,000. 0.04% of the stock is currently owned by hedge funds and other institutional investors.
About PureTech Health
(
Get Free Report)
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Stories
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
